Alcohol use disorder.
Conditions
Interventions
Intervention 1: Intervention group: The recipients of pregabalin capsules are from Galenus company, whose daily dose will gradually increase from 150 mg to 450 mg during the first three weeks of parti
Sponsors
Esfahan University of Medical Sciences
Eligibility
Sex/Gender
All
Age
18 Years to 65 Years
Inclusion criteria
Inclusion criteria: Confirmed alcohol use disorder based on DSM-5 criteria Drinking at least 5 standard units for men and 4 standard units for women at least 4 days a week in the last 28 days (every 14 grams of pure alcohol in any other halal amount is called one standard drinking unit) Informed consent to participate in the study
Exclusion criteria
Exclusion criteria: Reported history of previous allergy to pregabalin by the participant Pregnancy Breastfeeding Patients with renal disease Reported mental disorders by the participant that has been diagnosed by a doctor or psychologist at present or in the past Use of opioids, Cough medicine, marijuana, anti-anxiety medications, muscle relaxants, and antihistamines
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Score of craving to drink alcohol. Timepoint: Determining the craving to consume alcohol with a questionnaire, before the start of the study and in the second, fourth, sixth and eighth weeks after the start of the study. Method of measurement: Penn Alcohol Craving Scale standard quesionnaire. | — |
Countries
Iran (Islamic Republic of)
Contacts
Public ContactZahra Salehi
Esfahan University of Medical Sciences
Outcome results
None listed